Haematopoietic stem cell transplantation in Switzerland: A comprehensive quality control report on centre effect

Swiss Medical Weekly

Volumn 140, Issue 23-24, 2010, Pages 326-334

  Passweg, Jakob ^a,b   Baldomero, Helen ^b   Stern, Martin ^c   Bargetzi, Mario ^d   Ghielmini, Michele ^e   Leibundgut, Kurt ^f   Duchosal, Michel ^g   Hess, Urs ^h   Seger, Reinhard ⁱ   Buhrfeind, Eva ^b   Schanz, Urs ^j   Gratwohl, Alois ^c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Swiss Blood Stem Cells Registry   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d CANTONAL HOSPITAL AARAU   (Switzerland)

^e ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^f UNIVERSITY OF BERN   (Switzerland)

^g LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^h Kantonsspital St Gallen Division of Oncology Haematology   (Switzerland)

ⁱ UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^j UNIVERSITY HOSPITAL ZURICH   (Switzerland)

more..

Author keywords

Centre specific data; Haematopoietic stem cell transplantation; Outcome; Quality management

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHILD; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; QUALITY CONTROL; REFERENCE DATABASE; RETROSPECTIVE STUDY; SCHOOL CHILD; SURGICAL MORTALITY; SURGICAL RISK; SWITZERLAND; FACTUAL DATABASE; HEALTH CARE QUALITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MIDDLE AGED; MORTALITY; REGISTER; RISK FACTOR; STATISTICS; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; QUALITY ASSURANCE, HEALTH CARE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; SWITZERLAND; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77953487278     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Thomas ED. A history of allogeneic hematopoietic cell transplantation. In Thomas' Hematopoietic cell transplantation, Fourth Edition (Appelbaum FR, Forman S, Negrin RS, Blume KG Eds), Wiley Blackwell, Oxford, 2009, p. 3-7.
2. Armitage JO. The history of allogeneic hematopoietic cell transplantation. In Thomas' Hematopoietic cell transplantation, Fourth Edition (Appelbaum FR, Forman S, Negrin RS, Blume KG Eds), Wiley Blackwell, Oxford, 2009, p. 8-14.
3. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;27:1813-26.
4. Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med. 2007;11:1472-5.
5. Ljungman P, Bregni M, Brune M, Cornelissen J, Witte TD, Dini G, et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant. 2009; in press.
6. Gratwohl A, Baldomero H. Trends of hematopoietic stem cell transplantation in the third millennium. Curr Opin Hematol. 2009: in press.
7. Tan SS, Uyl de-Groot CA, Huijgens PC, Fibbe WE. Stem cell transplantation in Europe: trends and prospects. Eur J Cancer. 2007;43:2359-65.
8. Saito AM, Cutler C, Zahrieh D, et al. Costs of allogeneic hematopoietic cell transplantation with high-dose regimens. Biol Blood Marrow Transplant. 2008;14:197-207.
9. Howard RJ. The challenging triangle: balancing outcomes, transplant numbers and costs. Am J Transplant. 2007;7:2443-5.
10. Stahl JE, Vacanti JP, Gazelle S. Assessing emerging technologies - the case of organ replacement technologies: volume, durability, cost. Int J Technol Assess Health Care. 2007;23:331-6. (Pubitemid 46956890)
11. Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009;360:491-9.
12. Barkun JS, Aronson JK, Feldman LS, et al. Evaluation and stages of surgical innovations. Lancet. 2009;374:1089-96.
13. Ergina PL, Cook JA, Blazeby JM, et al. Challenges in evaluating surgical innovation. Lancet. 2009;374:1097-104.
14. McCulloch P, Altman DG, Campbell WB, et al. No surgical innovation without evaluation: the IDEAL recommendations. Lancet. 2009;374:1105-12.
15. Weiser TG, Makary MA, Haynes AB, Dziekan G, Berry WR, Gawande AA. Standardised metrics for global surgical surveillance. Safe Surgery Saves Lives Measurement and Study Groups. Lancet. 2009;374:1113-7.
16. Copnell B, Hagger V, Wilson SG, Evans SM, Sprivulis PC, Cameron PA. Measuring the quality of hospital care: an inventory of indicators. Intern Med J. 2009;39:352-60.
17. Larsen CR, Grantcharov T, Schouenborg L, Ottosen C, Soerensen JL, Ottesen B. Objective assessment of surgical competence in gynaecological laparoscopy: development and validation of a procedure-specific rating scale. BJOG. 2008;115: 908-16.
18. Westaby S, Archer N, Manning N, Adwani S, Grebenik C, Ormerod O, Pillai R, Wilson N. Comparison of hospital episode statistics and central cardiac audit database in public reporting of congenital heart surgery mortality. BMJ. 2007; 335:759.
19. Scott IA, Ward M. Public reporting of hospital outcomes based on administrative data: risks and opportunities. Med J Aust. 2006; 184:571-5.
20. Atherton K, Power C. Health inequalities with the National Statistics-Socioeconomic classification: disease risk factors and health in the 1958 British birth cohort. Eur J Public Health. 2007;17:486-91.
21. Oladapo OT, Adetoro OO, Fakeye O, Ekele BA, Fawole AO, Abasiattai A, et al.; the Nigerian Network for Reproductive Health Research and Training (NNRHRT). National data system on near miss and maternal death: shifting from maternal risk to public health impact in Nigeria. Reprod Health. 2009;6:8.
22. Farge D, Labopin M, Tyndall A, Fassas A, Mancardi GL, Van Laar J, et al. Autologous hematopoietic stem cell transplantation (HSCT) for autoimmune diseases: an observational study on 12 years of experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases. Haematologica. 2009, in press.
23. Peters C, Ladenstein R, Minkov M, Pötschger U, Gadner H, Cornish J, et al. Transplantation activities and treatment strategies in paediatric stem cell transplantation centres: a report from the EBMT Working Party on Paediatric Diseases. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 1998;22:431-7.
24. Nguyen GC, Thuluvath NP, Segev DL, Thuluvath PJ. Volumes of liver transplant and partial hepatectomy procedures are independently associated with lower postoperative mortality following resection for hepatocellular carcinoma. Liver Transpl. 2009;15:776-81.
25. Stiller CA, Draper GJ. Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia. Arch Dis Child. 1989;64:657-61.
26. Tracy ET, Bennett KM, Aviki EM, Pappas TN, Collins BH, Tuttle-Newhall JE, et al. Temporal trends in liver transplant centre volume in the USA. HPB (Oxford). 2009;11:414-21.
27. Gratwohl A, Baldomero H, Schwendener K, et al. Predictability of transplant rates. Haematologica. 2007;92:1679-86.
28. McKiernan PJ, Baker AJ, Kelly DA. The frequency and outcome of biliary atresia in the UK and Ireland. Lancet. 2000;355:25-9.
29. Legrand C, Ducrocq V, Janssen P, Sylvester R, Duchateau LA. Bayesian approach to jointly estimate centre and treatment by centre heterogeneity in a proportional hazards model. Stat Med. 2005;24:3789-804. (Pubitemid 43118218)
30. Kim SJ, Schaubel DE, Jeffery JR, Fenton SS. Centre-specific variation in renal transplant outcomes in Canada. Nephrol Dial Transplant. 2004;19:1856-61.
31. Briganti EM, Wolfe R, Russ GR, Eris JM, Walker RG, McNeil JJ. Graft loss following renal transplantation in Australia: is there a centre effect? Nephrol Dial Transplant. 2002;17: 1099-104.
32. Frassoni F, Labopin M, Powles R, Mary JY, Arcese W, Bacigalupo A, et al. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet. 2000;355:1393-8.
33. Keating S, de Witte T, Suciu S, Mandelli F, Damasio E, Willemze R, et al. Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A Study of the Leukemia Cooperative Group of the EORTC and GIMEMA. European Organization for Research and Treatment of Cancer (EORTC) Leukemia Cooperative Group and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA). Eur J Cancer. 1999;35:1440-7.
34. Sitta R, Lert F, Gueguen A, Spire B, Dray-Spira R; and the VESPA group. Hospitals: Results From the ANRS-EN12-VESPA Study. J Acquir Immune Defic Syndr. 2009, in press.
35. Udayaraj U, Tomson CR, Gilg J, Ansell D, Fogarty D. UK Renal Registry 11th Annual Report (December 2008): Chapter 6 Comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland: national and centre-specific analyses. Nephron Clin Pract. 2009;111(Suppl 1):c97-111.
36. Ravanan R, Udayaraj U, Steenkamp R, Ansell D. UK Renal Registry 11th Annual Report (December 2008): Chapter 5 Demographics and biochemistry profile of kidney transplant recipients in the UK in 2007: national and centre-specific analyses. Nephron Clin Pract. 2009;111(Suppl 1):c69-96.
37. Ansell D, Tomson CR. UK Renal Registry 11th Annual Report (December 2008): Chapter 15 The UK Renal Registry, UKRR database, validation and methodology. Nephron Clin Pract. 2009;111(Suppl.1):c277-85.
38. Putman K, De Wit L. European comparison of stroke rehabilitation. Top Stroke Rehabil. 2009;16:20-6.
39. Apolone G, Corli O, Caraceni A, Negri E, Deandrea S, Montanari M, Greco MT. Cancer Pain Outcome Research Study Group (CPOR SG) Investigators. Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group. Br J Cancer. 2009;100:1566-74.
40. Fiehler J, Jansen O, Berger J, Eckstein HH, Ringleb PA, Stingele R. Differences in complication rates among the centres in the SPACE study. Neuroradiology. 2008;50:1049-53.
41. Harrison DA, D'Amico G, Singer M. Case mix, outcome, and activity for admissions to UK critical care units with severe acute pancreatitis: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care. 2007;11(Suppl 1):S1.
42. Ferrara F, Fazi P, Venditti A, Pagano L, Amadori S, Mandelli F. Heterogeneity in the therapeutic approach to relapsed elderly patients with acute myeloid leukaemia: a survey from the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA). Acute Leukaemia Working Party. Hematol Oncol. 2008;26:104-7.
43. Kim SJ, Schaubel DE, Jeffery JR, Fenton SS. Centre-specific variation in renal transplant outcomes in Canada. Nephrol Dial Transplant. 2004;19:1856-61.
44. Reese PP, Feldman HI, McBride MA, Anderson K, Asch DA, Bloom RD. Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant. 2008;8:2062-70.
45. Kvalheim G, Gratwohl A, Urbano-Ispizua A; JACIE national representatives. JACIE accreditation in Europe moves ahead. Cytotherapy. 2003;5:306-8.
46. Donot PE. JACIE: from guidelines to clinical practice and continuous quality improvement, Léon-Bérard cancer center experience. The Bull Cancer. 2009;96:797-804.
47. Cornish JM. JACIE accreditation in paediatric haemopoietic SCT. Bone Marrow Transplant. 2008;42(Suppl. 2):S82-6.
48. Gratwohl A, Hermans J, Goldman JM, et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Lancet. 1998;352:1087-93.
49. Gratwohl A, Stern M, Brand R, Apperley J, Baldomero H, de Witte T, et al. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a Retrospective Analysis. Cancer. 2009; in press.
50. Petersdorf EW. Risk assessment in haematopoietic stem cell transplantation: histocompatibility. Best Pract Res Clin Haematol. 2007;20:155-70.
51. Dickinson AM, Harrold JL, Cullup H. Haematopoietic stem cell transplantation: can our genes predict clinical outcome? Expert Rev Mol Med. 2007;9:1-19.
52. Sorror ML, Sandmaier BM, Storer BE, et al. Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation. J Clin Oncol. 2007;25:4246-54.
53. Ljungman P. CMV infections after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008;42(Suppl 1): S70-S72.
54. Schlenk RF, Dohner K, Krauter J, et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008;358:1909-18.
55. De Witte T, Brand R, van Biezen A, Mufti G, Ruutu T, Finke J, et al.; European Blood and Marrow Transplantation Group (EBMT), Chronic Leukemia Working Party (CLWP)-MDS subcommittee. Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survival. Br J Haematol. 2009;146:627-36.
56. Kröger N, Brand R, van Biezen A, Zander A, Dierlamm J, Niederwieser D, et al.; Myelodysplastic Syndromes Subcommittee of The Chronic Leukaemia Working Party of European Group for Blood and Marrow Transplantation (EBMT). Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation. Haematologica. 2009;94:542-9.
57. Fouillard L, Labopin M, Gratwohl A, Gluckman E, Frassoni F, Beelen DW, et al.; Acute Leukemia Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission. Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2008;93:834-41.
58. Tangri N, Ansell D, Naimark D. Lack of a centre effect in UK renal units: application of an artificial neural network model. Nephrol Dial Transplant. 2006;21:743-8. (Pubitemid 43372924)
59. Dierich M, Fuehner T, Welte T, Simon A, Gottlieb J. Lung transplantation. Indications, long-term results and special impact of follow-up care. Internist (Berl). 2009;50:561-71.
60. Bechstein WO, Wullstein C. Transplantation and Outcome Quality. Chirurg. 2002;73:576-81.